ABBV
AbbVie Inc.
NYSE · Healthcare · Drug Manufacturers - General · US
$256.31
−1.50%Forward multiples
Based on analyst estimates
- P/E forward
- 16.88x
- P/E 2026E
- 18.34x
- P/E 2027E
- 15.76x
- P/E 2028E
- 14.35x
- P/S forward
- 6.47x
Trailing multiples
Trailing twelve months
- P/E TTM
- 72.21x
- PEG TTM
- 0.22x
- Price / book
- -76.32x
- Price / sales
- 7.03x
- Price / cash flow
- 23.22x
Enterprise value
- Enterprise value
- $517.2B
- EV / sales
- 8.03x
- EV / EBITDA
- 24.36x
- EV / EBIT
- 27.40x
- Market cap
- $452.9B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026